A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland.
The World Bank Group’s Pandemic Emergency Financing Facility (PEF) today made its first-ever financial commitment, approving a $12 million grant towards the current Ebola response in the Democratic Republic of the Congo (DRC). The grant, approved today at an emergency… Read More ›
IOM, the UN Migration Agency, is supporting the deployment of teams of epidemiologists and medical staff from the Ministry of Health and the National Programme of Hygiene at Borders (PNHF) in Kinshasa to 16 points of entry along the Democratic… Read More ›
The Government of Democratic Republic of the Congo has declared an outbreak of Ebola virus disease in the remote health zone of Bikoro, Equateur Province. The WHO is supporting the Ministry of Health and partners in the activation of an… Read More ›
Ebola virus can infect the reproductive organs of male and female macaques, according to a study published in The American Journal of Pathology, suggesting that humans could be similarly infected. Prior studies of survivors of the 2014-2016 Ebola outbreak in West Africa… Read More ›
Critical Collaboration Agreements for Ebola Vaccine Candidates Earn NIAID an Excellence in Technology Transfer Award
In 2014, as the Ebola outbreak escalated, NIAID collaborated with pharmaceutical company GlaxoSmithKline (GSK) on NIAID-planned clinical trials to test Ebola vaccine candidates. Their collaboration exemplifies the flexibility and creativity of the NIAID Technology Transfer and Intellectual Property Office (TTIPO),… Read More ›